Role of energy metabolic dficits and oxidative stress in extcitotoxic spinal motor neuron degeneration in vivo
Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR
The Weight-loss effect of GLP-1RAs Glucagon-Like Peptide-1 receptor agonists in Non-diabetic individuals with overweight or obesity: A systematic review with Meta-Analysis and trial sequential analysis of randomized controlled trials
The choice between oral and injectable semaglutide often hinges on patient preferences, lifestyle factors, and practical considerations beyond clinical efficacy
Overall, the benefits of GLP-1 agonists in terms of weight loss and improved metabolic health generally outweigh the potential risks, particularly when used under the guidance of a healthcare professional